Shanghai Pioneer Holding Ltd
1345.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.41B
Close$
$2.05
1.4% downside
Current Fair Value
1.4% downsideOvervalued by 1.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.41 Billion |
|---|---|
| Enterprise Value | $2.47 Billion |
| Dividend Yield | $0.12 (5.77%) |
| Earnings per Share | $0.1 |
| Beta | -0.16 |
| Outstanding Shares | 1,158,964,000 |
Return
| Return on Equity | 21.87% |
|---|---|
| Return on Assets | 14.14% |
| Return on Invested Capital | 25.63% |
Valuation & Multiples
| P/E Ratio | 16.53 |
|---|---|
| PEG | 91.08 |
| Price to Sales | 1.04 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.95 |
| Enterprise Value to EBIT | 8.25 |
| Enterprise Value to Net Income | 10 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shanghai Pioneer Holding Ltd
448 employees
CEO: Yuewen Yang China Pioneer Pharma Holdings Limited operates as an investment holding company, primarily focusing on the marketing, promotion, and distribution of pharmaceutical goods and medical devices within mainland China. The firm maintains an ex...